TesoRx Pharma, LLC Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

TesoRx Pharma, LLC is a biotechnology company focused on developing novel oral testosterone therapies for androgen deficiency. Its current program aims to deliver a first-in-class unmodified oral testosterone, with ongoing phase two trials and plans to begin phase three dosing by early 2026. Based in Menlo Park, California, the company operates on a small team and concentrates on advancing specialized pharmaceutical candidates through clinical development to address niche endocrine needs. In addition to its core testosterone program, TesoRx has a history of collaboration with ASKA Pharmaceutical, including efforts to develop and commercialize its products in Japan and parts of Southeast Asia, reflecting a strategy of international partnerships to expand reach in its target market.

Sign up for free to view info

Company overview Employee directory